Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
Frontiers | Ophthalmic Biomarkers for Alzheimer's Disease: A Review
Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease | Journal of the American Chemical Society
Amyloid-β: A double agent in Alzheimer's disease? - ScienceDirect
IJMS | Free Full-Text | Amyloid Beta in Aging and Alzheimer’s Disease
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study - The Lancet Neurology
Cells | Free Full-Text | Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer's Disease
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity | Biochemistry
Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | Scientific Reports
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
Frontiers | Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models: Cell
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? | PLOS Biology
Eric Topol on Twitter: "Just published @NEJM The Lecanemab randomized trial for Alzheimer's disese Reduced brain amyloid levels with only modest change in cognitive scores & increase in adverse events https://t.co/Fr3COh1DHc It
Biomarkers in Alzheimer's disease
Amyloid MS | Research & Development | SHIMADZU CORPORATION
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease - ScienceDirect
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Diagnostics | Free Full-Text | Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer's Disease
New Alzheimer's Biomarkers may Support Early Diagnosis
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches - The Lancet Neurology
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma - Michno - 2021 - Journal of Neurochemistry - Wiley Online Library
